The Europe Refractive Surgery Devices Market would witness market growth of 9% CAGR during the forecast period (2021-2027).
The introduction of various types of surgical equipment and instruments is the result of the major changes or advancements done in the ophthalmic surgical processes over the past years. Surgical robots are the latest innovation in refractive surgeries and work with high accuracy, offer error-free processes, and are highly reliable.
Further, the increasing number of patients with refractive errors and other eye conditions like dry eyes, presbyopia, hyperopia, myopia, and astigmatism would augment the refractive surgery device market. Refractive surgery helps the patient in decreasing or eliminating the use of contact lenses or glasses. In addition, this surgery eases the treatment of several eye diseases and vision correction that may lead to blindness. Based on the report by WHO, the major cause of vision impairment & blindness is uncorrected refractive errors and there are approximately millions of people suffering from this problem, across the globe. Therefore, these aspects are projected to accelerate the demand for refractive surgeries and hence, will lead to a significant surge in the growth of the market.
In Europe, Germany is dominating the refractive surgery devices market, owing to the growing research and enhancement in the ophthalmic lasers and refractive surgery device market. In France, the demand for refractive surgery devices is expanding, this is attributed to the increase in the number of patients with hyperopia and myopia. In addition, U.K. is also witnessing a significant surge in the demand for refractive surgery equipment due to an increase in the number of treatments and replacements in both the young and older generations.
Moreover, the regional refractive surgery devices market is expanding with factors like increasing adoption of surgical treatment, owing to the growing aging population and slightness concerns within them, among which refractive error is the most common problem in them, coupled with the high cost of refractive surgery may hamper the growth of the regional market in the upcoming years.
The Germany market dominated the Europe Ambulatory surgery centers Market by Country in 2020, thereby, achieving a market value of $6,457.2 Thousands by 2027. The UK market is exhibiting a CAGR of 8.3% during (2021 - 2027). Additionally, The France market is anticipated to witness a CAGR of 10.8% during (2021 - 2027).
Based on Application, the market is segmented into Astigmatism, Myopia, Hyperopia, Presbyopia, and Dry eyes. Based on Product, the market is segmented into Lasers, Microkeratome, Aberrometers and Other Products. Based on End Use, the market is segmented into Ophthalmology Clinics, Hospitals and Ambulatory surgery centers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Refractive Surgery Devices Market Size will Hit $331.5 million by 2027, at a CAGR of 9.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Carl Zeiss Meditec AG, Topcon Corporation, Novartis AG, Glaukos Corporation, Johnson & Johnson, Essilorluxottica SA, Bausch Health Companies, Inc., SCHWIND Eye-Tech-Solutions GmbH, NIDEK CO., LTD., and Quantel Medical (Lumibird Group).
By Application
By Product
By End Use
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 